Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -26,523 | -5,100 | N/A | N/A |
| Depreciation Amortization | 326 | 104 | N/A | N/A |
| Accounts payable and accrued liabilities | 631 | 367 | N/A | N/A |
| Other Working Capital | 282 | 174 | N/A | N/A |
| Other Operating Activity | -286 | -6,346 | 0 | 0 |
| Operating Cash Flow | $-25,570 | $-10,801 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2,318 | -630 | N/A | N/A |
| Investing Cash Flow | $-2,318 | $-630 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 247 | 38 | N/A | N/A |
| Other Financing Activity | 49,842 | 0 | 0 | 0 |
| Financing Cash Flow | $50,089 | $38 | $N/A | $N/A |
| Beginning Cash Position | 16,844 | 28,237 | N/A | N/A |
| End Cash Position | 39,045 | 16,844 | N/A | N/A |
| Net Cash Flow | $22,201 | $-11,393 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -25,570 | -10,801 | N/A | N/A |
| Capital Expenditure | -2,318 | -630 | N/A | N/A |
| Free Cash Flow | -27,888 | -11,431 | 0 | 0 |